Home
Live
News
Create
Screeners
Insights
Home
Solara Active Pharma Sciences - RE
Solara Active Pharma Sciences - RE
255.
50
-10.50
(-3.95%)
Overview
Peers
Financials
Balance Sheet
Cash Flows
Shareholding
Dividend
Corporate Actions
Announcements
Filings
Technicals
Market Cap
306.57 Cr
EPS
-
PE Ratio
-
Dividend Yield
0.00 %
Industry
0.00
52 Week High
554.95
52 Week Low
200.00
PB Ratio
2.16
Debt to Equity
-
Sector
0.00
1d
5d
1m
6m
1y
5y
Live Chart
compare with
Peers
...
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Buy
Sell
Analyst Rating
- By Refinitiv from
1 analysts
SELL
Analysts have suggested that investors can
sell this stock
Buy
0.0 %
0.0 %
Hold
0.0 %
0.0 %
Sell
+
100.
00
%
+
100.
00
%
Peer Comparison
Compare Peers on Screener
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Growth Rate
QoQ
1Y
3Y
5Y
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-
Quarterly Financial Results
Consolidated
Annual
Quarter
Balance Sheet
Consolidated
Cash Flow
Consolidated
Share Holding
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
No dividends have been distributed by the company in the past 10 years
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
Login
Open Account
Announcements
Closure of Trading Window
1 day ago
Record Date For The Purpose Of Making First Call For Rights Issue Equity Shares
1 day ago
Announcement under Regulation 30 (LODR)-Meeting Updates
1 day ago
Announcement under Regulation 30 (LODR)-Newspaper Publication
6 days ago
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
7 days ago
Grant Of ESOP Options
Feb 21, 2025
Closure Of Wholly Owned Subsidiary
Feb 21, 2025
Announcement under Regulation 30 (LODR)-Resignation of Managing Director
Feb 21, 2025
Announcement under Regulation 30 (LODR)-Change in Management
Feb 21, 2025
Announcement under Regulation 30 (LODR)-Change in Directorate
Feb 21, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Feb 10, 2025
Announcement under Regulation 30 (LODR)-Meeting Updates
Feb 07, 2025
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Jan 31, 2025
Integrated Filing (Financial)
Jan 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Jan 24, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Jan 24, 2025
Statement Of Deviation And Variation
Jan 24, 2025
Financial Results
Jan 24, 2025
Announcement Under Regulation 30 (LODR) - Update
Jan 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 13, 2025
Technical Indicators
RSI(14)
Neutral
47.14
ATR(14)
Volatile
17.47
STOCH(9,6)
Neutral
74.27
STOCH RSI(14)
Neutral
66.34
MACD(12,26)
Bullish
5.31
ADX(14)
Weak Trend
24.45
UO(9)
Bearish
53.24
ROC(12)
Downtrend And Accelerating
-3.62
WillR(14)
Neutral
-55.01